— Know what they know.
Not Investment Advice

ZOM AMEX

Zomedica Corp.
1W: -4.4% 1M: -39.2% 3M: -51.1% 1Y: -59.4% 3Y: -82.3% 5Y: -64.7%
$0.10
Last traded 2025-04-01 — delisted
AMEX · Healthcare · Drug Manufacturers - Specialty & Generic · $95.3M mcap · 962M float · 0.888% daily turnover
Smart Money Score
No convergence signal
Key Statistics
Market Cap$95.3M
52W Range0.0151-0.1952
Volume790,936
Avg Volume8,541,418
Beta1.16
Dividend
Analyst Ratings
1 Buy 0 Hold 0 Sell
Consensus Buy
Company Info
CEOLarry C. Heaton II
Employees144
SectorHealthcare
IndustryDrug Manufacturers - Specialty & Generic
IPO Date2017-11-21
100 Phoenix Drive
Ann Arbor, MI 48108
US
734 369 2555
About Zomedica Corp.

Zomedica Corp., a veterinary health company, focuses on the unmet needs of clinical veterinarians by developing products for companion animals. The company engages in the development and commercialization of TRUFORMA platform, which offers point-of-care diagnostic products for disease states in dogs and cats; and PulseVet, provides for treatment of various musculoskeletal issues, such as broken bones, tendonitis, and torn ligaments in horses and small animals. It has collaboration agreements with Celsee, Inc. for the development and commercialization of liquid biopsy assays and related consumables for the detection of cancer in companion animals; and Seraph Biosciences, Inc. for development and markets a novel pathogen detection system. The company was formerly known as Zomedica Pharmaceuticals Corp. and changed its name to Zomedica Corp. in October 2020. Zomedica Corp. was founded in 2015 and is headquartered in Ann Arbor, Michigan.

Latest News
No recent news

Recent Insider Trades

NameTypeSharesPriceDate
Rowe Jeffrey M P-Purchase 731,368 $0.07 2025-03-17
Rowe Jeffrey M P-Purchase 34,725 $0.07 2025-03-17
Rowe Jeffrey M P-Purchase 4,265 $0.07 2025-03-17
Rowe Jeffrey M P-Purchase 68,000 $0.07 2025-03-17
Rowe Jeffrey M P-Purchase 100,647 $0.07 2025-03-17

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms